You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 6, August 9, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Correction
 This Article
 •PDF of this Correction
 •Original article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Migraine and Risk of Cardiovascular Disease in Women—Correction

JAMA. 2006;296:654.

Unreported Financial Disclosures: In the Original Contribution entitled "Migraine and Risk of Cardiovascular Disease in Women" published in the July 19, 2006, issue of JAMA (2006;296:283-291), the following financial disclosures were not reported:

Dr Kurth has received investigator-initiated research grants from Bayer AG, McNeil Consumer & Specialty Pharmaceuticals, and Wyeth Consumer Healthcare; he is a consultant to i3 Drug Safety and has received an honorarium for contribution to an advisory board from Organon.

Dr Gaziano has received investigator-initiated research grants from BASF, DSM Pharmaceuticals, Wyeth Pharmaceuticals, McNeil Consumer Products, and Pliva; has received honoraria from Bayer and Pfizer for speaking engagements; and is a consultant for Bayer, McNeil Consumer Products, Wyeth Pharmaceuticals, Merck, Nutraquest, and GlaxoSmithKline.

Dr Cook has received research support from Roche Molecular Systems and has served as a consultant to Bayer.

Dr Logroscino has received honoraria for lectures from Pfizer and Lilly Pharmaceutical.

Dr Diener has received research support from Allergan, Almirall, AstraZeneca, Bayer, GlaxoSmithKline, Janssen-Cilag, and Pfizer; he has received honoraria for participation in clinical trials, contribution to advisory boards, or oral presentations from Allergan, Almirall, AstraZeneca, Bayer Vital, Berlin Chemie, Böhringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Grünenthal, Janssen-Cilag, Lilly, La Roche, 3M Medica, Merck Sharp & Dohme, Novartis, Johnson & Johnson, Pierre Fabre, Pfizer, Schaper & Brümmer, Sanofi-Aventis, and Weber & Weber.

Dr Buring has received an investigator-initiated grant from Dow Corning Corp; has received research support for pills and/or packaging from Bayer HealthCare and Natural Source Vitamin E Association; has received honoraria from Bayer for speaking engagements; and serves on an external Scientific Advisory Committee for Procter & Gamble.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reproducible Research: Moving toward Research the Public Can Really Trust
Laine et al.
ANN INTERN MED 2007;146:450-453.
ABSTRACT | FULL TEXT  

Migraine and Cardiovascular Outcomes in Women
JWatch Neurology 2006;2006:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.